A local firm is getting a leg up from the government of Quebec in its mission to restore vision to the blind.
Ottawa-based iBIONICS is developing a patented technology that could help blind people to see by capturing visual data with a specialized pair of glasses and sending those electronic signals to the brain through a diamond-based implant in the eye.
The Quebec government announced Thursday the startup will receive a total of $438,400 in financing from the Quebec Life Sciences Strategy. The 10-year, $205-million fund is meant to foster innovation in the province’s health-care system and set firms up to attract private investment down the line.
(Sponsored)
Desjardins Elevator Pitch Competition drives entrepreneurial energy at uOttawa
In uOttawa’s Desjardins Elevator Pitch Competition, a single team member stands before the judges, pitching for three minutes, fielding questions for five. There are no decks, notes, props or prototypes
How Carleton is using simulation and visualization to improve training, design and human performance
From healthcare to aviation to architecture, simulation and visualization tools have become an essential part of training, analysis and decision-making in sectors that rely on precision. At Carleton University, researchers
In a statement, iBIONICS CEO and co-founder Suzanne Grant said the extra cash will set the firm up to raise an equity round later this fall. Coming in to 2018, the firm had raised roughly US$4 million between grants and public and private funding sources.
“If you have a highly-purposed mission within your project, the level of support you get is very different,” Grant told Techopia Live earlier this year.
